T
Tempest Therapeutics D
D
TPST
6.93000
USD
0.26
(3.90%)
مغلق
حجم التداول
5,414
الربح لكل سهم
-13
العائد الربحي
-
P/E
-0
حجم السوق
25,519,226
العنوان: Tempest Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.